Advances in the Pathogenesis of Alzheimer's Disease: Focusing on Tau-mediated Neurodegeneration

Overview

Journal Transl Neurodegener

Publisher Biomed Central

Date 2012 Dec 18

PMID 23241453

Citations 38

Authors

Yale Duan

Suzhen Dong

Feng Gu

Yinghe Hu

Zheng Zhao

Affiliations

Soon will be listed here.

Abstract

In addition to senile plaques and cerebral amyloid angiopathy, the hyperphosphorylation of tau protein and formation of intraneuronal neurofibrillary tangles (NFTs) represents another neuropathological hallmark in AD brain. Tau is a microtubule-associated protein and localizes predominantly in the axons of neurons with the primary function in maintaining microtubules stability. When the balance between tau phosphorylation and dephosphorylation is changed in favor of the former, tau is hyperphosphorylated and the level of the free tau fractions elevated. The hyperphosphorylation of tau protein and formation of NFTs represent a characteristic neuropathological feature in AD brain. We have discussed the role of Aβ in AD in our previous review, this review focused on the recent advances in tau-mediated AD pathology, mainly including tau hyperphosphorylation, propagation of tau pathology and the relationship between tau and Aβ.

Citing Articles

Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer's Disease.

Abdelhamid M, Counts S, Zhou C, Hida H, Kim J, Michikawa M Nutrients. 2025; 17(3).

PMID: 39940416 PMC: 11820889. DOI: 10.3390/nu17030558.

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.

Flieger J, Forma A, Flieger W, Flieger M, Gawlik P, Dzierzynski E Int J Mol Sci. 2024; 25(16).

PMID: 39201668 PMC: 11354426. DOI: 10.3390/ijms25168982.

Polysaccharides from Protect Post-Mitotic Neurons against Cell Cycle Re-Entry and Apoptosis Induced by the Amyloid-Beta Peptide by Blocking Sonic Hedgehog Expression.

Hou B, Wu M, Hsu H, Lin Y, Yang D Int J Mol Sci. 2024; 25(13).

PMID: 39000427 PMC: 11242684. DOI: 10.3390/ijms25137316.

Plasma phosphorylated tau181 as a biomarker of mild traumatic brain injury: findings from THINC and NCAA-DoD CARE Consortium prospective cohorts.

Devoto C, Vorn R, Mithani S, Meier T, Lai C, Broglio S Front Neurol. 2023; 14:1202967.

PMID: 37662031 PMC: 10470112. DOI: 10.3389/fneur.2023.1202967.

Spermidine Rescues Bioenergetic and Mitophagy Deficits Induced by Disease-Associated Tau Protein.

Fairley L, Lejri I, Grimm A, Eckert A Int J Mol Sci. 2023; 24(6).

PMID: 36982371 PMC: 10049002. DOI: 10.3390/ijms24065297.

References

Sperber B, Leight S, Goedert M, Lee V . Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Neurosci Lett. 1995; 197(2):149-53. DOI: 10.1016/0304-3940(95)11902-9. View

Sjoberg M, Shestakova E, Mansuroglu Z, Maccioni R, Bonnefoy E . Tau protein binds to pericentromeric DNA: a putative role for nuclear tau in nucleolar organization. J Cell Sci. 2006; 119(Pt 10):2025-34. DOI: 10.1242/jcs.02907. View

Irwin D, Cohen T, Grossman M, Arnold S, Xie S, Lee V . Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain. 2012; 135(Pt 3):807-18. PMC: 3286338. DOI: 10.1093/brain/aws013. View

Lee K, CLARK A, Rosales J, Chapman K, Fung T, Johnston R . Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neurosci Res. 1999; 34(1):21-9. DOI: 10.1016/s0168-0102(99)00026-7. View

Goedert M, Spillantini M, Jakes R, Rutherford D, Crowther R . Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 1989; 3(4):519-26. DOI: 10.1016/0896-6273(89)90210-9. View

Wang J, Xia Y, Grundke-Iqbal I, Iqbal K . Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis. 2012; 33 Suppl 1:S123-39. DOI: 10.3233/JAD-2012-129031. View

Ittner L, Ke Y, Delerue F, Bi M, Gladbach A, van Eersel J . Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell. 2010; 142(3):387-97. DOI: 10.1016/j.cell.2010.06.036. View

de Calignon A, Polydoro M, Suarez-Calvet M, William C, Adamowicz D, Kopeikina K . Propagation of tau pathology in a model of early Alzheimer's disease. Neuron. 2012; 73(4):685-97. PMC: 3292759. DOI: 10.1016/j.neuron.2011.11.033. View

Kim I, Park E, Seo J, Ko S, Lee J, Kim C . Zinc stimulates tau S214 phosphorylation by the activation of Raf/mitogen-activated protein kinase-kinase/extracellular signal-regulated kinase pathway. Neuroreport. 2011; 22(16):839-44. DOI: 10.1097/WNR.0b013e32834c0a2d. View

10.

SantaCruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M . Tau suppression in a neurodegenerative mouse model improves memory function. Science. 2005; 309(5733):476-81. PMC: 1574647. DOI: 10.1126/science.1113694. View

11.

Hyman B, Trojanowski J . Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol. 1997; 56(10):1095-7. DOI: 10.1097/00005072-199710000-00002. View

12.

Wang J, Grundke-Iqbal I, Iqbal K . Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci. 2007; 25(1):59-68. PMC: 3191918. DOI: 10.1111/j.1460-9568.2006.05226.x. View

13.

Frost B, Jacks R, Diamond M . Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem. 2009; 284(19):12845-52. PMC: 2676015. DOI: 10.1074/jbc.M808759200. View

14.

Drewes G, Ebneth A, Preuss U, Mandelkow E, Mandelkow E . MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell. 1997; 89(2):297-308. DOI: 10.1016/s0092-8674(00)80208-1. View

15.

Hurtado D, Molina-Porcel L, Carroll J, Macdonald C, Aboagye A, Trojanowski J . Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease. J Neurosci. 2012; 32(21):7392-402. PMC: 3368584. DOI: 10.1523/JNEUROSCI.0889-12.2012. View

16.

Lee V, Goedert M, Trojanowski J . Neurodegenerative tauopathies. Annu Rev Neurosci. 2001; 24:1121-59. DOI: 10.1146/annurev.neuro.24.1.1121. View

17.

Martin L, Latypova X, Terro F . Post-translational modifications of tau protein: implications for Alzheimer's disease. Neurochem Int. 2011; 58(4):458-71. DOI: 10.1016/j.neuint.2010.12.023. View

18.

Rhein V, Song X, Wiesner A, Ittner L, Baysang G, Meier F . Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci U S A. 2009; 106(47):20057-62. PMC: 2774257. DOI: 10.1073/pnas.0905529106. View

19.

King M, Kan H, Baas P, Erisir A, Glabe C, Bloom G . Tau-dependent microtubule disassembly initiated by prefibrillar beta-amyloid. J Cell Biol. 2006; 175(4):541-6. PMC: 2064590. DOI: 10.1083/jcb.200605187. View

20.

Patzke H, Tsai L . Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29. J Biol Chem. 2002; 277(10):8054-60. DOI: 10.1074/jbc.M109645200. View